Cite
Effectiveness and Safety of Enteric-Coated vs Uncoated Aspirin in Patients With Cardiovascular Disease: A Secondary Analysis of the ADAPTABLE Randomized Clinical Trial.
MLA
Sleem, Amber, et al. “Effectiveness and Safety of Enteric-Coated vs Uncoated Aspirin in Patients With Cardiovascular Disease: A Secondary Analysis of the ADAPTABLE Randomized Clinical Trial.” JAMA Cardiology, vol. 8, no. 11, Nov. 2023, pp. 1061–69. EBSCOhost, https://doi.org/10.1001/jamacardio.2023.3364.
APA
Sleem, A., Effron, M. B., Stebbins, A., Wruck, L. M., Marquis-Gravel, G., Muñoz, D., Re, R. N., Gupta, K., Pepine, C. J., Jain, S. K., Girotra, S., Whittle, J., Benziger, C. P., Farrehi, P. M., Knowlton, K. U., Polonsky, T. S., Roe, M. T., Rothman, R. L., Harrington, R. A., & Jones, W. S. (2023). Effectiveness and Safety of Enteric-Coated vs Uncoated Aspirin in Patients With Cardiovascular Disease: A Secondary Analysis of the ADAPTABLE Randomized Clinical Trial. JAMA Cardiology, 8(11), 1061–1069. https://doi.org/10.1001/jamacardio.2023.3364
Chicago
Sleem, Amber, Mark B. Effron, Amanda Stebbins, Lisa M. Wruck, Guillaume Marquis-Gravel, Daniel Muñoz, Richard N. Re, et al. 2023. “Effectiveness and Safety of Enteric-Coated vs Uncoated Aspirin in Patients With Cardiovascular Disease: A Secondary Analysis of the ADAPTABLE Randomized Clinical Trial.” JAMA Cardiology 8 (11): 1061–69. doi:10.1001/jamacardio.2023.3364.